TRANSMEDICS GROUP INC (TMDX) Stock Analyst Ratings
NASDAQ:TMDX • US89377M1099
148 USD
+1 (+0.68%)
At close: Mar 3, 2026
147.32 USD
-0.68 (-0.46%)
After Hours: 3/3/2026, 8:00:01 PM
ChartMill assigns a Buy % Consensus number of 83% to TMDX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 148.92. This target is 0.62% above the current price.
- TMDX was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TMDX.
- In the previous month the buy percentage consensus was at a similar level.
- TMDX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-25 | Needham | Maintains | Buy -> Buy |
| 2026-02-25 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-25 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-25 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-08 | Needham | Maintains | Buy -> Buy |
| 2025-12-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-23 | Needham | Upgrade | Hold -> Buy |
| 2025-10-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-13 | Jefferies | Initiate | Buy |
| 2025-09-16 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-04 | Stifel | Initiate | Hold |
| 2025-08-25 | Needham | Reiterate | Hold -> Hold |
| 2025-08-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-06-17 | Needham | Reiterate | Hold -> Hold |
| 2025-06-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-04 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-06-03 | Needham | Reiterate | Hold -> Hold |
| 2025-05-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-09 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-04-29 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-04-23 | Needham | Reiterate | Hold -> Hold |
| 2025-03-26 | Needham | Reiterate | Hold -> Hold |
| 2025-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-05 | Needham | Reiterate | Hold -> Hold |
| 2024-12-17 | JP Morgan | Downgrade | Overweight -> Neutral |
TRANSMEDICS GROUP INC / TMDX FAQ
What do analysts expect the price target to be for TRANSMEDICS GROUP INC (TMDX)?
20 analysts have analysed TMDX and the average price target is 148.92 USD. This implies a price increase of 0.62% is expected in the next year compared to the current price of 148.
How do analysts rate TRANSMEDICS GROUP INC (TMDX)?
The consensus rating for TRANSMEDICS GROUP INC (TMDX) is 83 / 100 . This indicates that analysts generally have a positive outlook on the stock.